Bienczak, A., Denti, P., Cook, A., Wiesner, L., Mulenga, V., Kityo, C., Kekitiinwa, A., Gibb, D. M., Burger, D., Walker, A. S., & McIlleron, H. (2016). Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children. JAIDS Journal of Acquired Immune Deficiency Syndromes, 73(2), 161–168. https://doi.org/10.1097/QAI.0000000000001032
Bienczak, A., Cook, A., Wiesner, L., Mulenga, V., Kityo, C., Kekitiinwa, A., Walker, A. S., Owen, A., Gibb, D. M., Burger, D., McIlleron, H., & Denti, P. (2016). Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children [Epub ahead of print]. Journal of Antimicrobial Chemotherapy, 71(10), dkw388. https://doi.org/10.1093/jac/dkw388
Orrell, C., Bienczak, A., Cohen, K., Bangsberg, D., Wood, R., Maartens, G., & Denti, P. (2016). Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy. International Journal of Antimicrobial Agents, 47(6), 466–472. https://doi.org/10.1016/j.ijantimicag.2016.03.017
Bienczak, A., Cook, A., Wiesner, L., Olagunju, A., Mulenga, V., Kityo, C., Kekitiinwa, A., Owen, A., Walker, A. S., Gibb, D. M., McIlleron, H., Burger, D., & Denti, P. (2016). The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children. British Journal of Clinical Pharmacology, 82(1), 185–198. https://doi.org/10.1111/bcp.12934
Chirehwa, M. T., Rustomjee, R., Mthiyane, T., Onyebujoh, P., Smith, P., McIlleron, H., & Denti, P. (2016). Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction. Antimicrobial Agents and Chemotherapy, 60(1), 487 LP – 494. https://doi.org/10.1128/AAC.01830-15
Denti, P., Martinson, N., Cohn, S., Mashabela, F., Hoffmann, J., Msandiwa, R., Castel, S., Wiesner, L., Chaisson, R. E., McIlleron, H., & Dooley, K. E. (2016). Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa. Antimicrobial Agents and Chemotherapy, 60(3), 1234 LP – 1241. https://doi.org/10.1128/AAC.02051-15
Hoffmann, C. J., Cohn, S., Mashabela, F., Hoffmann, J. D., McIlleron, H., Denti, P., Haas, D. W., Dooley, K. E., Martinson, N. A., & Chaisson, R. E. (2016). Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 71(1), 31–37. https://doi.org/10.1097/QAI.0000000000000811